Related references
Note: Only part of the references are listed.Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581
Alan P. Venook et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer
Sang Cheul Oh et al.
GUT (2012)
Identification of a Poor-Prognosis BRAF-Mutant-Like Population of Patients With Colon Cancer
Vlad Popovici et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
Arnaud D. Roth et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue
Richard D. Kennedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
Richard G. Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial
Fred T. Bosman et al.
CLINICAL CANCER RESEARCH (2009)
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
Robert N. Jorissen et al.
CLINICAL CANCER RESEARCH (2009)
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer
Yuqiu Jiang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer
Yu-Hsin Lin et al.
CLINICAL CANCER RESEARCH (2007)
Stage II colon cancer prognosis prediction by tumor gene expression profiling
Alain Barrier et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
L Ein-Dor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dichotomizing continuous predictors in multiple regression: a bad idea
P Royston et al.
STATISTICS IN MEDICINE (2006)
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer
D Arango et al.
GASTROENTEROLOGY (2005)
Molecular staging for survival prediction of colorectal cancer patients
S Eschrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Opinion - Rules of evidence for cancer molecular-marker discovery and validation
DF Ransohoff
NATURE REVIEWS CANCER (2004)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression profiles and molecular markers to predict recurrence of dukes' B colon cancer
YX Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
